Sort   by:  
 Page size 
UnknownCirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients.
Not available
S-EPMC3722882 | biostudies-literature
UnknownInteraction between PNPLA3 I148M variant and age at infection in determining fibrosis progression in chronic hepatitis C.
Not available
S-EPMC4149487 | biostudies-literature
UnknownPrevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort.
Not available
S-EPMC10813305 | biostudies-literature
UnknownDEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.
Not available
S-EPMC4737289 | biostudies-literature
UnknownTocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Not available
S-EPMC7576974 | biostudies-literature
UnknownInterleukin-2 therapy in patients with HIV infection.
Not available
S-EPMC2869083 | biostudies-literature
UnknownDevelopment and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Not available
S-EPMC4380415 | biostudies-literature
UnknownSeverity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Not available
S-EPMC4309077 | biostudies-literature
Sort   by:  
 Page size